ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-OR119

Interaction of SHROOM3 with FYN Impacts Phosphorylation of Nephrin Causing Proteinuria with Foot Process Effacement

Session Information

Category: Transplantation

  • 1701 Transplantation: Basic and Experimental

Authors

  • Menon, Madhav C., Mount Sinai School of Medicine, Forest Hills, New York, United States
  • Philippe, Nimrod, Mount Sinai Hospital, New York, New York, United States
  • Wei, Chengguo, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Liu, Ruijie, Mount Sinai Medical School, New York, New York, United States
  • Wong, Jenny, Mount Sinai School of Medicine, Forest Hills, New York, United States
  • Yi, Zhengzi, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Zhang, Weijia, Mount Sinai School of Medicine, Forest Hills, New York, United States
  • He, John C., Mount Sinai School of Medicine, Forest Hills, New York, United States
  • Murphy, Barbara T., Icahn School of Medicine at Mount Sinai, New York, New York, United States
Background

In the GoCAR study, we identified that a CKD-associated SHROOM3-SNP, and tubular Shroom3 expression correlated with the development of renal fibrosis post-transplant. We showed that SHROOM3 facilitated TGF-B signaling suggesting its potential role as a therapeutic target. However, recent data suggest a protective role for SHROOM3 in glomerular development.

Methods

To study the role of SHROOM3 in adult glomeruli, we used doxycycline-inducible (DOX), shRNA-mediated SHROOM3 knockdown, Podocin- and tubular-specific (PAX8)-RTTA mice, comparing these to non-transgenic DOX-fed littermates.

Results

Adult Podo-RTTA mice, but not PAX8-RTTA, developed significant albuminuria compared to littermates with DOX. Albuminuria was reversible on DOX-withdrawal, and reappeared on re-initiation. EM revealed diffuse foot process effacement (Fig1). Glomerular RNA-seq identifed downregulated intracellular signaling/ actin-cytoskeleton among Gene-ontology terms in knockdown mice. We performed mass spectrometry on protein lysates of 293-T cells overexpressing SHROOM3 immunoprecipitated (IP) with either anti-V5, -SHROOM3 or IgG. Among 491 unique interactions, we identified FYN – a src-kinase – as a top ranking candidate. Podocyte FYN is crucial for NPHS1-phosphorylation, and FYN-deficient mice show a proteinuria phenotype. In human podocytes, we confirmed the interaction of endogenous SHROOM3 and FYN by IP. Glomerular protein extracts of Shroom3-knockdown mice showed decreased phosphorylation of FYN, and NPHS1. In human allografts from GoCAR, we identifed a corresponding reduced albuminuria (>1year post-transplant) associated with homozygosity of the risk allele in the donor.

Conclusion

In summary, Podocyte-specific SHROOM3 knockdown causes a reversible proteinuria phenotype in adult mice, by interacting with FYN, a mechanism distinct from its effect on renal fibrosis in allografts.